Topics

EpimAb Company Profile

04:01 EST 23rd January 2020 | BioPortfolio


News Articles [6 Associated News Articles listed on BioPortfolio]

Shanghai's EpimAb Completes $74 Million Series B for Bi-Specific Antibodies

EpimAb Biotherapeutics, a Shanghai bi-specifics company focused on cancer and immunotherapies, closed a $74 million Series B financing. The company uses its FIT-Ig® (Fabs-In-Tandem Immunoglobulin)...

China's EpimAb Biotherapeutics Raises $74 Million in Series B to Advance Solid Tumor Therapy

EpimAb plans to use the funds to advance its Phase I/II clinical program, EMB01, expand its clinical pipeline into immuno-oncology and other areas and add a new manufacturing site in Suzhou for proces...

Series B round brings in $74mm for EpimAb

EpimAb Biotherapeutics Inc. (bispecific antibodies for cancer) raised $74mm through its Series B round co-led by new board members SDIC Fund and Sherpa Healthcare Partners. Also participating were SCV...

EpimAb raises $74M series B round to accelerate bispecific immuno-oncology pipeline expansion

How EpimAb plans to use its $74M series B to accelerate its bispecific pipeline of immuno-oncology candidates.

@EpimAb_Bio EpimAb Biotherapeutics

Our CBO, Stephan Lensky, is presenting at the 26th @BioCentury #NewsMakers in #NYC on September 6. Stop by and reach out if you’re interested in a meeting! http://bit.ly

EpimAb Biotherapeutics Raises $74M in Series B Financing

Funding to be used in growing and advancing the Company’s clinical pipeline of novel bispecific antibodies EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutic...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

EpimAb Biotherapeutics EpimAb Biotherapeutics

EpimAb Biotherapeutics is a privately-owned biopharmaceutical R&D company based in Shanghai with a proprietary and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunogl...

EpimAb Biotherapeutics

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company based in Shanghai with a proprietary unique and efficient technology called FIT-Ig® (Fabs-In-Tandem...

EpimAb

More Information about "EpimAb" on BioPortfolio

We have published hundreds of EpimAb news stories on BioPortfolio along with dozens of EpimAb Clinical Trials and PubMed Articles about EpimAb for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EpimAb Companies in our database. You can also find out about relevant EpimAb Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record